Certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulation, 2018 for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Limited has submitted a routine compliance certificate to BSE under SEBI Regulation 74(5) for the quarter ended June 30, 2025. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), Satellite Corporate Services Pvt. Ltd. It confirms that no physical share certificates were received from shareholders for dematerialization during the quarter. The filing was signed by Sohan Chaturvedi, Whole Time Director & CFO, on July 7, 2025.
This is a routine quarterly regulatory filing with no material impact on shareholders or the stock price. It simply confirms compliance with SEBI rules on share dematerialization and indicates no physical-to-demat conversion activity occurred during the quarter.